From: The dual role of microRNA (miR)-20b in cancers: Friend or foe?
Cell type | Biological process | Signal pathway | Target genes | Potential diseases | References |
---|---|---|---|---|---|
Vascular smooth muscle cells | Blood pressure | – | MAGI3 | Hypertension | [25] |
Endothelial cells | Autophagy | HIF-1 | ULK1 | – | [26] |
Placental trophoblast cells | Viability | – | MCL-1 | Preeclampsia | [27] |
Smooth muscle cells | Proliferation | STAT3 | PDGF | Asthma | [28] |
Trophoblast cell | Migration | – | MMP-2 | Preeclampsia | [29] |
T Cell | Proliferation and Activation | NFAT | NFAT5 and CAMTA1 | Myasthenia Gravis | [30] |
Mesenchymal stem cells | Differentiation | Notch | Ngn2, MAP2, and TUBB3 | – | [31] |
Lung tissues cells | Apoptosis | Mitochondrial intrinsic pathway | MFN1 and MFN2 | Lung injury | [32] |
Cardiac cell | Apoptosis and Differentiation | BMP | – | Heart diseases | [33] |
Chondrocyte | Proliferation and autophagy | PI3K/AKT/mTOR | ATG10 | Osteoarthritis | [34] |
Neurons | Differentiation | WNT | NRSF/REST | Neurological disorders | [35] |
Macrophage-derived foam cells | Cholesterol metabolism | – | ABCA1 | Atherosclerosis | [36] |
pluripotent stem cells | Apoptosis | Intrinsic pathway | BIM | – | [37] |
Hematopoietic stem cell | Differentiation | – | MAFB | – | [38] |
Macrophage and kidney | Lipid metabolism | Epigenetic pathways | ABCA1, ABCG1, and SCARBI | Atherosclerosis | [39] |
Multipotent Stromal Cells | Cell cycle and DNA synthesis | – | p21, CCND1, and E2F1 | – | [40] |
Human umbilical vein endothelial cells | Cell senescence | Wnt/beta-catenin | TXNIP | Cardiovascular disease | [41] |
Cardiomyocytes | Apoptosis | NF-kappa B | HIF-1 alpha | Cardiovascular disease | [23] |